SCHEMBL932205

SCHEMBL932205

CC1=NC(c2cccc(N)c2)(C2CC2)N=C1N

nearest known ligand 0.61

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.61
KCNH2 Q12809 6/20 0.61
BACE2 Q9Y5Z0 6/20 0.61
APP P05067 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932230 0.86 BACE1 (0.59) BACE1KCNH2BACE2APP
SCHEMBL931281 0.81 BACE1 (0.60) BACE1KCNH2BACE2APP
SCHEMBL932626 0.80 BACE1 (0.65) BACE1KCNH2BACE2APP
SCHEMBL6892665 0.79 BACE1 (0.80) BACE1KCNH2BACE2APP
SCHEMBL943175 0.77 BACE1 (1.00) BACE1KCNH2BACE2APP
SCHEMBL931244 0.75 BACE1 (0.46) BACE1KCNH2BACE2
SCHEMBL932191 0.75 BACE1 (0.51) BACE1KCNH2BACE2APP
SCHEMBL931846 0.75 BACE1 (0.82) BACE1KCNH2BACE2
SCHEMBL6894615 0.74 BACE1 (0.73) BACE1KCNH2BACE2APP
SCHEMBL931835 0.74 BACE1 (1.00) BACE1KCNH2BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed